Tech Company Financing Transactions

Seawolf Therapeutics Funding Round

On 11/16/2026, Seawolf Therapeutics raised $100 million in funding from MPM Capital, Novartis Venture Fund and Versant Ventures.

Transaction Overview

Announced On
11/16/2026
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to advance its portfolio of therapeutics leveraging its redosable lipid nanoparticle (LNP)-based DNA delivery system, including advancing its lead program for metabolic diseases and executing its multi-target research collaboration with Sanofi.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9880 Campus Point Drive 210
San Diego, CA 92121
USA
Email Address
Overview
Seawolf Therapeutics is unlocking the full potential of DNA-based medicines to transform how diseases are addressed. Our proprietary TRIDENT� technology, a redosable lipid nanoparticle (LNP)-based DNA delivery system, delivers DNA payloads to cells with unparalleled potency and safety to drive robust, sustained expression of therapeutic proteins.
Profile
Seawolf Therapeutics LinkedIn Company Profile
Social Media
Seawolf Therapeutics Company Twitter Account
Company News
Seawolf Therapeutics News
Facebook
Seawolf Therapeutics on Facebook
YouTube
Seawolf Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elizabeth Alcamo
  Elizabeth Alcamo LinkedIn Profile  Elizabeth Alcamo Twitter Account  Elizabeth Alcamo News  Elizabeth Alcamo on Facebook
Chief Scientific Officer
Rob Burke
  Rob Burke LinkedIn Profile  Rob Burke Twitter Account  Rob Burke News  Rob Burke on Facebook
VP - Engineering
Ramon Trelles
  Ramon Trelles LinkedIn Profile  Ramon Trelles Twitter Account  Ramon Trelles News  Ramon Trelles on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/16/2026: Corma venture capital transaction
Next: 11/16/2026: Subdial venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary